News | March 31, 2026
Roche launches groundbreaking multiplex test to boost blood safety
The new assay consolidates screening for four major viral threats into a single workflow
The new assay consolidates screening for four major viral threats into a single workflow
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The company plans to submit the vaccine for regulatory review
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
Subscribe To Our Newsletter & Stay Updated
